Antiretroviral Therapy Suppresses RNA N 6 -Methyladenosine Modification in Peripheral Blood Mononuclear Cells from HIV-1-Infected Individuals
AIDS Research and Human Retroviruses · 2024
DOI: 10.1089/aid.2024.0003 ↗Kurz gefasst
Fachartikel in der Zeitschrift AIDS Research and Human Retroviruses, 2024. Verfasst von Tarun Mishra und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA. Hauptthemen laut MEDLINE: Leukocytes, Mononuclear, HIV Infections, HIV-1, Adenosine. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, NIAID NIH HHS.
Abstract (Originalsprache)
RNA N6-methyladenosine (m6A) modification is important for regulating gene expression and innate immune responses to viral infection. HIV-1 in vitro infection induces a significant increase in m6A modification of cellular RNA; however, whether m6A levels of cellular RNA are affected by HIV-1 replication or by antiretroviral therapy (ART) in infected individuals remains unknown. Using dot blot or enzyme-linked immunosorbent assay, we measured RNA m6A levels of peripheral blood mononuclear cells (PBMCs) from healthy donors or HIV-1-infected individuals with or without ART. Using a reverse transcription-quantitative polymerase chain reaction array, we quantified expression levels of 84 type-I interferon (IFN-I)-responsive genes in PBMCs from some individuals of these three groups. RNA m6A levels in PBMCs from HIV-1 viremic patients (n = 10) were significantly higher (p ≤ .0001) compared with ART-treated individuals (n = 22) or 1.5-fold higher compared with healthy donors (n = 14). However, the increase in RNA m6A levels did not correlate with changes in the expression of 10 m6A-regulatory genes. We found significant upregulation and downregulation in the expression of several IFN-I-responsive genes from HIV-1 viremic patients (n = 4) and ART-treated patients (n = 6) compared with healthy donors (n = 5), respectively. Our results suggest that post-transcriptional m6A modification may contribute to the regulation of IFN-I-responsive gene expression during HIV-1 infection and ART.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
- Division of Infectious Diseases, Department of Internal Medicine, Carver College of Medicine, University of Iowa, The Iowa City VA Healthcare System, Iowa City, Iowa, USA.
ORCID-Profile: Li Wu
Förderung
- BLRD VA
- NIAID NIH HHS
Zitieren
APA
Mishra, T., Phillips, S., Maldonado, C., Stapleton, J. T., & Wu, L. (2024). Antiretroviral Therapy Suppresses RNA N 6 -Methyladenosine Modification in Peripheral Blood Mononuclear Cells from HIV-1-Infected Individuals. AIDS Research and Human Retroviruses. https://doi.org/10.1089/aid.2024.0003
Vancouver
Mishra T, Phillips S, Maldonado C, Stapleton JT, Wu L. Antiretroviral Therapy Suppresses RNA N 6 -Methyladenosine Modification in Peripheral Blood Mononuclear Cells from HIV-1-Infected Individuals. AIDS Research and Human Retroviruses. 2024. doi:10.1089/aid.2024.0003
BibTeX
@article{Mishra2024,
author = {Mishra, Tarun and Phillips, Stacia and Maldonado, Crystal and Stapleton, Jack T and Wu, Li},
title = {Antiretroviral Therapy Suppresses RNA N 6 -Methyladenosine Modification in Peripheral Blood Mononuclear Cells from HIV-1-Infected Individuals},
journal = {AIDS Research and Human Retroviruses},
year = {2024},
doi = {10.1089/aid.2024.0003}
}
EUVIMED